参考文献/References:
[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127: 2893- 2917.
[2] Prajapati HJ, Dhanasekaran R, El- Rayes BF, et al. Safety and efficacy of doxorubicin drugeluting bead transarterial chemoembo- lization in patients with advanced hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2013, 24: 307- 315.
[3] Petruzzi NJ, Frangos AJ, Fenkel JM, et al. Single- center compa- rison of three chemoembolization regimens for hepato- cellular carcinoma[J]. J Vasc Interv Radiol, 2013, 24: 266- 273.
[4] Ngan H, Lai CL, Fan ST, et al. Transcatheter arterial chemoembo- lization in inoperable hepatocellular carcinoma: four- year follow- up[J]. J Vasc Interv Radiol, 1996, 7: 419- 425.
[5] 王绍胜, 张文堃, 董 杰. 新型温敏性栓塞剂用于脑动静脉畸形实验研究[J]. 介入放射学杂志, 2010, 19: 471- 474.
[6] 盛希忠, 刘作勤, 武乐斌, 等. 新型温度敏感性液体栓塞材料的实验研究[J]. 医学影像学杂志, 2005, 15: 177- 180.
[7] 李敬伟, 王 杰, 吕朋华, 等. 非黏附性液体栓塞剂-BCD合剂的实验研究[J]. 中国临床医学影像杂志, 2005, 16: 156- 160.
[8] 万智勇, 张 磊, 卢子碹, 等. 温敏药物缓释栓塞剂行兔肝动脉栓塞的实验研究[J]. 介入放射学杂志, 2011, 20: 559- 562.
[9] 曹艳霞, 张 灿, 平其能. 温度敏感型材料聚(N-异丙基丙烯酰胺)壳聚糖的制备与表征[J]. 高分子材料科学与工程, 2005, 21: 236- 239.
[10] 杜 浩, 马廉亭, 吴佐泉, 等. 非黏附液体栓塞材料甲基丙烯酸羟乙酯聚合物的溶解及栓塞性能[J]. 中国组织工程研究与临床康复, 2008, 12: 9643- 9646.
[11] Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Semin Radiat Oncol, 2003, 13: 176- 181.
[12] Lencioni R, Llovet JM. Modified RECIST(mRECIST) assessment for hepatocellular carcinoma[J]. Semin Liver Dis, 2010, 30: 52- 60.
[13] 姚雪松, 李 槐. 不可手术切除的肝细胞癌的疗效评价标准——改良RECIST标准更可靠[J]. 介入放射学杂志, 2012, 21: 177- 179.
[14] Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J]. Lancet, 2002, 359: 1734- 1739.
[15] 敖 劲, 张跃伟, 徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J]. 介入放射学杂志, 2011, 20: 1010- 1013.
[16] Xu H, Yang R, Wang X, et al. Symptomatic pulmonary lipiodol embolism after transarterial chemoembolization for hepatic malignant tumor: clinical presentation and chest imaging findings[J]. Chin Med J(Engl), 2014, 127: 675- 679.
[17] 刘 朝, 管 生, 李明省, 等. 肝脏肿瘤介入术后碘油异位脑栓塞(附报道2例并文献复习)[J]. 介入放射学杂志, 2011, 20: 135- 137.
[18] Camma C, Schepis F, Orlando A, et al. Transarterial chemoembo- lization for unresectable hepatocellular carcinoma: meta- analysis of randomized controlled trials[J]. Radiology, 2002, 224: 47- 54.
[19] 刘 影, 张跃伟. 肝癌介入治疗用微粒型栓塞剂的研究进展[J]. 介入放射学杂志, 2012, 21: 969- 972.
[20] Heskins M, Guillet JE. Solution properties ofpoly(N- isopropyla- crylamide). Macromol Sci Chem (A), 1968, 2: 1441- 1455.
[21] Matsumaru Y, Hyodo A, Nose T, et al. Application of thermosen- sitive polymers as a new embolic material for intravascular neuro- surgery[J]. J Biomater Sci Polym Ed, 1996, 7: 795- 804.
[22] 盛希忠, 刘作勤, 武乐斌, 等. 温敏型液体栓塞材料的实验研究[J]. 实用放射学杂志, 2005, 21: 1233- 1236.
[23] 盛希忠, 刘作勤, 赵成如, 等. 温度敏感型液体栓塞剂治疗脑动静脉畸形的实验研究[J]. 中国医学影像技术, 2005, 21: 1353- 1355.
[24] Pothmann D, Ulusans S, Prols F, et al. Liquid 2- P- HEMA for endovascular tumor therapy: in vivo feasibility study[J]. Med Sci Monit, 2004, 10: BR286- BR293.
相似文献/References:
[1]贾雨辰,程红岩,陈栋,等.原发性肝癌的介入治疗[J].介入放射学杂志,1997,(02):113.
[2].介入放射学杂志1997年 第6卷总目录第1期[J].介入放射学杂志,1997,(04):251.
[3]郭建魁,刘志伟.肝动脉灌注栓塞术治疗肝癌的疗效[J].介入放射学杂志,1998,(03):174.
[4]韩旭,杨家政,左庆云,等.选择性肝动脉灌注化疗及栓塞治疗原发性巨块型肝癌[J].介入放射学杂志,1998,(03):171.
[5]周洪超,王冬,徐涛,等.晚期肝癌介入综合治疗评价(附38例报告)[J].介入放射学杂志,1999,(01):44.
[6]陆莎莎,程永德.动脉灌注化疗与栓塞治疗肝癌后声像图变化的探讨[J].介入放射学杂志,1992,(01):43.
[7]陈伟敏,罗佐权.肝癌肝动脉灌注化疗与静脉输注硫代硫酸钠的“双路”疗法18例报告[J].介入放射学杂志,1992,(01):26.
[8]卢小军,吴锦章,朱松英,等.肝动脉化疗并栓塞治疗肝癌并发急性胰腺炎2例[J].介入放射学杂志,1993,(01):28.
[9]李麟荪.为我国介入放射学事业的发展而努力[J].介入放射学杂志,1993,(01):3.
[10]夏晓,陆进.经腹腔动脉门脉造影:门脉高压32例分析[J].介入放射学杂志,1994,(02):101.